image credit: Adobe Stock

Study shows Syn-One Test’s ability to identify alpha-synuclein in skin

April 27, 2023

CND Life Sciences has announced that its Syn-One Test was able to identify the pathological form of alpha-synuclein in the skin of more than 95% of patients diagnosed with synucleinopathy in the Synuclein-One study.

Synucleinopathies are a group of disorders with worsening neurological deficits. Patients with synucleinopathies are diagnosed with conditions such as Parkinson’s disease, multiple system atrophy, dementia with Lewy bodies and pure autonomic failure.

Read More on Medical Device Network